
|Articles|November 1, 2004
Look to Cells, not Site, to Diagnose B-Cell Lymphoma
Because morphology, bcl-2 expression and multicentricity are the strongest predictive factors in multivariate analysis of PCDLBCL, Dr. Ellis proposes that primary subdivision of PCBCL according to anatomic location be abandoned in favor of classification by centroblast/immunoblast morphology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
JAK Inhibitors Show Comparable Safety to TNF Antagonists
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5


















